@article{81f664e08a3e49cd87e140938eab7dcc,
title = "Varenicline modulates spatial working memory deficits in smokers with schizophrenia",
author = "Wing, \{Victoria C.\} and Wass, \{Caroline E.\} and Ingrid Bacher and Rabin, \{Rachel A.\} and George, \{Tony P.\}",
note = "Funding Information: This research was supported by an operating grant from the Ontario Mental Health Foundation (to T.P.G.), the Canada Foundation for Innovation Research Hospital Fund (CFI-RHF \# 16014 , to T.P.G.), the Canada Foundation for Innovation Leader Opportunity Fund (CFI-LOF \# 19229 , to T.P.G.), an operating grant from the Canadian Institutes of Health Research (MOP \# 115145 to T.P.G. and V.C.W.), and the Chair in Addiction Psychiatry from the University of Toronto (to T.P.G). V.C.W. and C.E.W were supported by Postdoctoral Fellowship Awards from the Centre for Addiction and Mental Health (CAMH) . Varenicline tartrate was provided by Pfizer, Canada under an Investigator Initiated Research Agreement. The funding agencies had no role in the design of the study or analysis and interpretation of the findings. ",
year = "2013",
month = sep,
doi = "10.1016/j.schres.2013.06.032",
language = "English",
volume = "149",
pages = "190--191",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier B.V.",
number = "1-3",
}